Cannabis Research

A New Frontier for Medicare The Trump administration has officially authorized a groundbreaking pilot program this week, allowing select Medicare patients access to cannabidiol (CBD) to address chronic health conditions. This initiative, launched across various clinical sites nationwide, aims to determine whether the non-psychoactive cannabis compound can effectively manage symptoms in older populations while simultaneously…